Lymphocytes 2022
Where it went: 2023
Zanubrutinib is not generally considered a “miracle drug,” but it represents a major advancement in treating certain blood cancers, particularly chronic lymphocytic leukemia (CLL).
It is a next-generation BTK inhibitor, blocking the protein that helps cancer cells survive & proliferate.
That’s amazing, Gary! YAY!!!
Thanks, YAY! is right. You can see the crazy rough patch last year at this time.